KFA
RMD icon

Kelleher Financial Advisors’s ResMed RMD Stock Holding History

Kelleher Financial Advisors’s Portfolio RMD Stock Details RMD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$46.8K Hold
240
– – 0.01% 448
2026
Q1 		$61.9K Hold
240
– – 0.02% 348
2025
Q4 		$57.8K Hold
240
– – 0.01% 384
2025
Q3 		$65.7K Buy
+240
New +$65.6K 0.02% 311

Other funds holding RMD

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return
First Trust Advisors
First Trust Advisors Wheaton, Illinois $170B AUM 46.21% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return

Kelleher Financial Advisors's RMD Position: Q2 2026 in Review

Kelleher Financial Advisors held its ResMed (RMD) position steady in Q2 2026 at 240 shares worth $46.8K. The position accounts for 0.01% of the portfolio, ranked #448.

Kelleher Financial Advisors first reported a position in RMD in Q3 2025 and has held it in 4 quarters since. The position peaked at $65.7K in Q3 2025. 891 funds tracked by Wall St. Rank hold RMD as of Q2 2026.

  • Kelleher Financial Advisors held 240 shares of ResMed worth $46.8K as of Q2 2026.
  • Kelleher Financial Advisors left its ResMed share count unchanged in Q2 2026.
  • ResMed made up 0.01% of Kelleher Financial Advisors's portfolio in Q2 2026, its #448 holding.
  • Kelleher Financial Advisors first reported a position in ResMed in Q3 2025 and has held it in 4 quarters since.
  • Kelleher Financial Advisors's ResMed position peaked at $65.7K in Q3 2025.
  • 891 funds tracked by Wall St. Rank held ResMed as of Q2 2026.

Based on Kelleher Financial Advisors's 13F filing for Q2 2026, filed 6 Aug 2026.